Voriconazole
Indication: Invasive aspergillosis, candidemia
Population pharmacokinetic simulator for intravenous voriconazole in critically ill ICU patients with pulmonary disease. One-compartment model (CL=4.28 L/h, Vd=93.4 L) with direct bilirubin covariate effect on clearance. Based on Chen et al. 2015.
Drug Overview
Clinical Context
- Molecular Target
- Ergosterol biosynthesis (CYP51A1)
- Drug Class
- Triazole Antifungal
- Therapeutic Area
- Infectious Disease
- Indication
- Invasive aspergillosis, candidemia
- Route of Administration
- IV
Model Information
- Model Type
- One-compartment PopPK
This simulator was built from published pharmacometric literature using PKPDBuilder's AI-powered model extraction pipeline.
About This Simulator
This interactive pharmacokinetic simulator for Voriconazole allows you to explore concentration-time profiles under different dosing scenarios. The underlying One-compartment PopPK model characterizes the pharmacokinetics of this triazole antifungal following iv administration.
Use the simulator to visualize key exposure metrics including AUC (area under the curve), Cmax (peak concentration), and Ctrough (trough concentration).
Built with PKPDBuilder — an AI-powered platform that transforms published pharmacometric literature into interactive, deployable Shiny applications. No coding required.
Frequently Asked Questions
What is the Voriconazole PK simulator?
This is a free, interactive pharmacokinetic simulator for Voriconazole used in Invasive aspergillosis, candidemia. It allows researchers, pharmacologists, and students to explore concentration-time profiles, dosing regimens, and exposure metrics based on published population PK models.
What drug class does Voriconazole belong to?
Voriconazole is classified as a Triazole Antifungal that targets Ergosterol biosynthesis (CYP51A1). It is used in the Infectious Disease therapeutic area.
What route of administration does this model simulate?
This simulator models IV administration of Voriconazole. The pharmacokinetic parameters (absorption rate, bioavailability, volume of distribution) are specific to this route.
What type of PK model is used?
This simulator uses a One-compartment PopPK model. Population PK models account for interindividual variability and covariate effects on drug exposure.
Is this simulator free to use?
Yes, all PKPDBuilder simulators are completely free. They are built from published pharmacokinetic literature and are intended for research and educational purposes. No login is required to run simulations.
Can I use this for clinical dosing decisions?
No. This simulator is for research and educational purposes only. It should not be used for clinical decision-making or patient dosing. Always consult the prescribing information and clinical pharmacology guidelines for therapeutic drug use.
Related Simulators
Oxfendazole Population PK — Tablet Formulation in Healthy African Adults
Onchocerciasis (river blindness)
Shingrix (Recombinant Zoster Vaccine) PK Simulator
Shingles prevention
Prevnar 20 (PCV20) PK Simulator
Pneumococcal disease prevention
Paxlovid (Nirmatrelvir/Ritonavir) PK Simulator
COVID-19 treatment
Gardasil 9 (9-valent HPV Vaccine) PK Simulator
HPV-related cancer prevention
Comirnaty (BNT162b2) PK Simulator
COVID-19 prevention
Ready to Simulate?
Launch the Voriconazole simulator to explore dosing scenarios and pharmacokinetic profiles interactively.
🚀 Launch SimulatorComments
⚠️ Disclaimer
This simulator is for research and educational purposes only. It is not intended for clinical decision-making, patient dosing, or therapeutic drug monitoring. Pharmacokinetic parameters are derived from published literature and represent population-level estimates. Individual patient pharmacokinetics may differ significantly. Always consult approved prescribing information and qualified healthcare professionals for clinical decisions.
Powered by PKPDBuilder.com • Free pharmacokinetic simulators for the scientific community